{'fraction_non_alphanumeric': 0.044167610419026046, 'fraction_numerical': 0.02491506228765572, 'mean_word_length': 4.559748427672956, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
In vitro trials of a wearable artificial kidney (WAK)

Background: This paper presents results of in vitro trials of a wearable artificial kidney (WAK). Materials and methods: To carry out the trials, a test bench was developed. It consisted of a patient imitator, a tubing set and measuring equipment. Results: Our WAK can eliminate urea, uric acid and creatinine from spent dialysate with mean mass rates of 0.85 ± 0.1 g/h, 0.10 ± 0.04 g/h and 0.05 ± 0.01 g/h, respectively. Concentrations of Na+, Cl– and Ca2+ ions were kept in the 10% range from initial values. We demonstrated that our WAK can operate for 38 hours without having to replace expendable materials. Conclusions: The WAK that we developed can eliminate metabolites from spent dialysis fluid with mass rates that are sufficient to maintain stable, physiologically normal metabolite concentrations in patients’ blood.